Disclosure of interest: Nothing to disclose Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P262 - ESOC25-1312 DISCHARGE RATES TO HOME FOLLOWING RECURRENT ISCHEMIC STROKE (IS): A REAL-WORLD DATA ANALYSIS ON THE CURRENT PATIENT JOURNEY IN THE US Mark Alberts 1 , Jenny Jiang 2 , Yan Wang 3 , Arimanda Reddy 4 , Haitham Alabsi 5 , Meg Thompson 5 , Merena Henderson 2 , Xiaoyan Li 2 , Priyanka Gaitonde 2 1 Hartford HealthCare, Hartford, United States, 2 Bristol Myers Squibb, Lawrenceville, United States, 3 Analysis Group Inc., Los Angeles, United States, 4 Mu-Sigma, Chicago, United States, 5 Johnson & Johnson, Raritan, United States Background and Aims: A significant proportion of IS patients experience recurrent IS within five years
Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate metabolic reprogramming of stored red blood cells
Unleash the Regenerative Power of SPIERECTOR (BPC 157)
Speaker: Ms Roberta Cucca (Norwegian University of Life Sciences (NMBU)) T_14 ETHICS, VALUES AND PLANNING: Conceptions of Justice in Planning A1-06 (YTU Davutpasa Campus) A1-06 YTU Davutpasa Campus Conveners: Brett Allen Slack, Stefano Cozzolino (ILS - Research Institute for Regional and Urban Development) 51 Planning for gender health justice: A scoping review and research agenda Urban planning plays a crucial role in advancing social justice, public health, and gender equity in parallel
This data can then be leveraged to guide genetic/metabolic engineering strategies for targeted phenotypes (i.e., lipid overproduction)
